Analysis of the CC chemokine receptor 5 (CCR5)Delta 32 polymorphism in Behcet's disease (vol 31, pg 11, 2004)

Analysis of the CC chemokine receptor 5 (CCR5)Delta 32 polymorphism in Behcet's disease (vol 31, pg 11, 2004)

Bibliografiska uppgifter
Huvudupphovsmän:	Yang, X, Ahmad, T, Gogus, F, Verity, D, Wallace, G, Madanat, W, Kanawati, C, Stanford, MR, Fortune, F, Jewell, D, Marshall, SE
Materialtyp:	Journal article
Publicerad:	2005

Liknande verk

CARD15 polymorphisms in Behcet's disease.
av: Ahmad, T, et al.
Publicerad: (2005)

In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases
av: Veronika Sekerova, et al.
Publicerad: (2003-01-01)

Computational study of the structural ensemble of CC chemokine receptor type 5 (CCR5) and its interactions with different ligands.
av: Guillermo Goode-Romero, et al.
Publicerad: (2022-01-01)

Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
av: Ericsson-Dahlstrand Anders, et al.
Publicerad: (2007-05-01)

Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis
av: Kvien Tore K, et al.
Publicerad: (2007-06-01)

The case for selection at CCR5-Delta32.
av: Pardis C Sabeti, et al.
Publicerad: (2005-11-01)

The frequency of CCR5 promoter polymorphisms and CCR5 32 mutation in Iranian populations
av: Mohammad Zare-Bidaki, et al.
Publicerad: (2015-04-01)

Clinical observation of an HIV-infected patient heterozygous for the mutant allele of the CCR5 del 32 chemokine receptor
av: Z. I. Akhmedjanova, et al.
Publicerad: (2021-07-01)

Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5
av: Hui Zhang, et al.
Publicerad: (2021-07-01)

The case for selection at CCR5-Delta32.
Publicerad: (2005-11-01)

Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis
av: Wei, Z, et al.
Publicerad: (2005)

Chemokines and chemokine receptors in Behçet’s disease
av: Zhan Li, et al.
Publicerad: (2023-01-01)

Prevalence of CCR5delta32 in Northeastern Iran
av: Amir Tajbakhsh, et al.
Publicerad: (2019-11-01)

The chemokine receptor CCR5: multi-faceted hook for HIV-1
av: Natacha Faivre, et al.
Publicerad: (2024-01-01)

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
av: Daniele Di Marino, et al.
Publicerad: (2023-10-01)

Intragenus (Homo) variation in a chemokine receptor gene (CCR5).
av: Kara C Hoover
Publicerad: (2018-01-01)

The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection
av: Assunta Venuti, et al.
Publicerad: (2017-10-01)

Distribution of the CCR5delta32 allele (gene variant CCR5) in Rondônia, Western Amazonian region, Brazil
av: Josileide Duarte de Farias, et al.
Publicerad: (2012-01-01)

Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19.
av: Daniel Clark Files, et al.
Publicerad: (2022-06-01)

Upregulation of expression of the chemokine receptor CCR5 by hydrogen peroxide in human monocytes
av: Geneviève Lehoux, et al.
Publicerad: (2003-01-01)

Mutant Chemokine Receptor (CCR-5) and Its Relevance to HIV Infection in Arabs
av: Iman H. Al-Sheikh, et al.
Publicerad: (1999-02-01)

Impact of CCR5Δ32 on the risk of infection, Staphylococcus aureus carriage, and plasma concentrations of chemokines in Danish blood donorsResearch in context
av: Khoa Manh Dinh, et al.
Publicerad: (2024-11-01)

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection <it>in vitro </it>without blocking gp120/CCR5 interaction
av: Lever Andrew ML, et al.
Publicerad: (2005-04-01)

Antagonist of chemokine receptors CCR1 and CCR3
av: Ammit Alaina, et al.
Publicerad: (2000-11-01)

Association of chemokine receptor gene (<it>CCR2-CCR5</it>) haplotypes with acquisition and control of HIV-1 infection in Zambians
av: Hunter Eric, et al.
Publicerad: (2011-03-01)

Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation.
av: Duncan, S, et al.
Publicerad: (2005)

Frequency of CCR5Δ32 allele in healthy Bosniak population.
av: Grażyna Adler, et al.
Publicerad: (2014-08-01)

Clinical significance of the CCR5delta32 allele in hepatitis C.
av: Isabelle Morard, et al.
Publicerad: (2014-01-01)

The frequency of allele CCR5Δ32 in a Serbian population
av: Đorđević Valentina, et al.
Publicerad: (2013-01-01)

The geographic spread of the CCR5 Delta32 HIV-resistance allele.
av: John Novembre, et al.
Publicerad: (2005-11-01)

HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation.
av: Chunxia Qi, et al.
Publicerad: (2016-01-01)

The geographic spread of the CCR5 Delta32 HIV-resistance allele.
Publicerad: (2005-11-01)

CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.
av: Djin-Ye Oh, et al.
Publicerad: (2008-01-01)

A Set of Experimentally Validated Decoys for the Human CC Chemokine Receptor 7 (CCR7) Obtained by Virtual Screening
av: Matic Proj, et al.
Publicerad: (2022-03-01)

CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.
av: Satsangi, J, et al.
Publicerad: (2000)

Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions
av: Inês Pinheiro, et al.
Publicerad: (2024-01-01)

CCR5 genotype and plasma ß-chemokine concentration of Brazilian HIV-infected individuals
av: Mikawa A.Y., et al.
Publicerad: (2002-01-01)

CC chemokine CCL1 receptor CCR8 mediates conversion of mesenchymal stem cells to embryoid bodies expressing FOXP3+CCR8+ regulatory T cells.
av: Nasreen S Haque, et al.
Publicerad: (2019-01-01)

HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
av: Gupta, R, et al.
Publicerad: (2019)

CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5
av: Dirk Lassner, et al.
Publicerad: (2018-09-01)